Mesenchymal stem/stromal cells (MSCs) are undergoing intensive translational research for
several debilitating conditions, including critical illnesses such as ARDS and sepsis. MSCs …

Mesenchymal stem/stromal cells (MSCs) have demonstrated efficacy in pre-clinical models
of inflammation and tissue injury, including in models of lung injury and infection. Rolling, …

What We Already Know about This Topic Human mesenchymal stromal cells diminish injury
and enhance recovery and repair after ventilator-induced lung injury in animals Current …

Coronavirus pneumonia is accompanied by rapid virus replication, where a large number of
inflammatory cell infiltration and cytokine storm may lead to acute lung injury, acute …

Background Mesenchymal stromal cells (MSCs) demonstrate considerable promise in
preclinical acute respiratory distress syndrome models. We wished to determine the efficacy and …

Background: Mesenchymal stromal cells (MSCs) have been demonstrated to attenuate acute
lung injury when delivered by intravenous or intratracheal routes. The authors aimed to …

Background: Rodent mesenchymal stem/stromal cells (MSCs) enhance repair after
ventilator-induced lung injury (VILI). We wished to determine the therapeutic potential of human …

Acute respiratory distress syndrome (ARDS) is driven by a severe pro-inflammatory response
resulting in lung damage, impaired gas exchange and severe respiratory failure. There is …

Editor’s Perspective What We Already Know about This Topic Mesenchymal stromal cells
are multipotent adult stem cells with the capacity to differentiate into multiple cell types and …

Sepsis and acute respiratory distress syndrome (ARDS) constitute devastating conditions
with high morbidity and mortality. Sepsis results from abnormal host immune response, with …